Initial studies involve tiny amounts of muscle.
Families not involved in these experiments are not excluded from anything beneficial at this stage. A total of between six and twelve people will receive these injections over an interval of several weeks. LGMD is the name of a group of disorders, which primarily affect the muscles of the hip and shoulder girdle. To remove bias neither the investigators nor the patient will know which foot received which injection. Six weeks later muscle biopsies will be taken from both feet and compared.